A Focus On Expediting Drug Development Congress has instructed the Food and Drug Administration (FDA) to expedite the development and review of promising new drugs through the creation of four programs: accelerated approval, fast-track, breakthrough
Read More...
Read the complete post at http://healthaffairs.org/blog/2017/10/06/nearly-one-third-of-new-drugs-are-no-better-than-older-drugs-and-some-are-worse/
Posted
Oct 06 2017, 06:00 AM
by
Health Affairs BlogHealth Affairs Blog